MPCCC Clinical Trial Centres 2020-05-22T11:56:20+00:00

MPCCC Clinical Trial Centres

MPCCC’s clinical and research partners include established translational research centres with extensive experience in cancer clinical trials to offer better treatment options for cancer patients.

Alfred Health Clinical Trials Clinical research is central to patient care at The Alfred, where leading practitioners who are also leading researchers care for the state’s most complex patients.

Cabrini Health Cancer Trials offers access to a wide spectrum of newly advanced treatments including immunotherapeutic drugs and targeted therapies for a range of solid and haematological malignancies.

Eastern Health Clinical Research Unit is involved in more than 150 active clinical trials, with more than 1,500 patients. A large team of over 40 clinical trial coordinators work with a variety of investigating groups.

Epworth Health Haematology Clinical Trials Unit manages a broad clinical trials portfolio offering early to late phase studies with a focus on non-Hodgkin lymphoma and multiple myeloma

Monash Health Oncology and Haematology Research Unit is one of the largest clinical trials units in Melbourne, experienced in the conduct of Phase I, Phase II, Phase III and Phase IV studies. Many studies have a strong translational component with correlative laboratory studies on biopsy and surgical specimens, to allow maximal understanding of cancer and how it is affected by new treatments.

Monash Health Translation Precinct Clinical Trials Centre has facilitated more than 200 clinical trials within the MHTP Clinical Trials Centre to date. In an Australian first, the facility supports research conducted at Monash University and the Hudson Institute of Medical Research in collaboration with Monash Health, the largest public health service in Victoria.